BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6178597)

  • 1. Demonstration of two distinct light chains in HLA-DR-associated antigens by two-dimensional gel electrophoresis.
    de Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Mar; 12(3):214-21. PubMed ID: 6178597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
    De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical analysis of the polymorphism of three HLA-D region antigens.
    de Kretser T; Crumpton MJ; Bodmer JG; Bodmer WF
    Mol Biol Med; 1983 Jul; 1(1):59-76. PubMed ID: 6593560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two-dimensional gel analyses of HLA-D region antigens by the use of monoclonal antibodies].
    Takenouchi T
    Hokkaido Igaku Zasshi; 1983 May; 58(3):279-91. PubMed ID: 6194092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two dimensional gel analysis of HLA-DR2 associated HLA-D clusters.
    Nakatsuji T; Moriya K; Tsuji K
    Tokai J Exp Clin Med; 1986 May; 11(2):125-31. PubMed ID: 3031855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structural analysis of DR and DQ molecules among three HLA-D clusters associated with HLA-DR4].
    Ikeda H
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):898-907. PubMed ID: 2417927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HLA-DR antigens: cellular expression and molecular structure].
    Charron DJ
    Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.
    Lloyd KO; Ng J; Dippold WG
    J Immunol; 1981 Jun; 126(6):2408-13. PubMed ID: 6785352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
    Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
    J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HLA-D-region antigens by two-dimensional gel electrophoresis. Molecular-genotyping.
    Charron DJ; McDevitt HO
    J Exp Med; 1980 Aug; 152(2 Pt 2):18s-36s. PubMed ID: 6931876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sheep MHC class II molecules. II. Identification and characterization of four distinct subsets of sheep MHC class II molecules.
    Puri NK; Brandon MR
    Immunology; 1987 Dec; 62(4):575-80. PubMed ID: 3480873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HLA-DR antigens on leukaemic cells.
    Newman RA; Greaves MF
    Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.